Fenton Mary Kay

Chief Financial Officer at CGEM; Officer at Talaris Therapeutics, Inc.; Chief Financial Officer at ACHILLION PHARMACEUTICALS INC

Sold, on record
$982k
Dollars the filings state
Form 4 sales
7
Latest Feb 20, 2026
Form 144 notices
1
Proposed sales
Companies
3
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
1
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale ACHILLION PHARMACEUTICALS INCUnusual
    Jan 13, 2011 2011

    Sold 8,750 shares at $5.00 ($44k)

    Fenton Mary Kay, SVP and CFO

    Sold 40.9% of holdings ($107k position)12,625 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale ACHILLION PHARMACEUTICALS INCUnusual
    Mar 30, 2011 +76 days

    Sold 4,000 shares at $7.50 ($30k)

    Fenton Mary Kay, SVP and CFO

    Sold 31.7% of holdings ($95k position)8,625 shares leftFiling

  3. 3 Form 4 sale ACHILLION PHARMACEUTICALS INCUnusual
    Apr 6, 2011 +7 days

    Sold 4,250 shares at $7.50 ($32k)

    Fenton Mary Kay, SVP and CFO

    Sold 49.3% of holdings ($65k position)4,375 shares leftFiling

  4. 4 Form 4 sale ACHILLION PHARMACEUTICALS INCUnusual
    Jan 10, 2012 +279 days

    Sold 15,000 shares at $11.22 ($168k)

    Fenton Mary Kay, SVP and CFO

    Sold 100% of holdings ($168k position)0 shares left3.5x usual sizeFiling

  5. 5 Form 4 sale ACHILLION PHARMACEUTICALS INCUnusual
    Jan 23, 2015 +1109 days

    Sold 13,125 shares at $16.00 ($210k)

    Fenton Mary Kay, EVP and CFO

    Sold 100% of holdings ($210k position)0 shares leftFirst sale on recordFiling

  6. 6 Form 4 sale ACHILLION PHARMACEUTICALS INCUnusual
    Dec 28, 2015 +339 days

    Sold 43,500 shares at $10.08 ($438k)

    Fenton Mary Kay, Chief Financial Officer

    Sold 100% of holdings ($438k position)0 shares leftFiling

  7. 7 Form 144 notice Talaris Therapeutics, Inc.Notice
    Jul 5, 2023 +2746 days

    Filed to sell 12,946 shares ($40k)

    Fenton Mary Kay, Officer

    No 10b5-1 planFirst sale on recordFiling

  8. 8 Form 4 sale CGEMNo plan
    Feb 20, 2026 +961 days

    Sold 4,398 shares at $13.62 ($60k)

    Fenton Mary Kay, Chief Financial Officer

    No 10b5-1 planSold 3.4% of holdings ($1.8M position)126,380 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (8)

Form 144 notices and Form 4 sales by Fenton Mary Kay
Source
Feb 20, 2026Feb 23, 2026CGEMChief Financial OfficerForm 4 sale4,398$60k3.4%No planSEC
Jul 5, 2023Jul 5, 2023Talaris Therapeutics, Inc.OfficerForm 144 notice12,946$40kNoticeSEC
Dec 28, 2015Dec 30, 2015ACHILLION PHARMACEUTICALS INCChief Financial OfficerForm 4 sale43,500$438k100.0%UnusualSEC
Jan 23, 2015Jan 23, 2015ACHILLION PHARMACEUTICALS INCEVP and CFOForm 4 sale13,125$210k100.0%UnusualSEC
Jan 10, 2012Jan 11, 2012ACHILLION PHARMACEUTICALS INCSVP and CFOForm 4 sale15,000$168k100.0%UnusualSEC
Apr 6, 2011Apr 6, 2011ACHILLION PHARMACEUTICALS INCSVP and CFOForm 4 sale4,250$32k49.3%UnusualSEC
Mar 30, 2011Apr 1, 2011ACHILLION PHARMACEUTICALS INCSVP and CFOForm 4 sale4,000$30k31.7%UnusualSEC
Jan 13, 2011Jan 18, 2011ACHILLION PHARMACEUTICALS INCSVP and CFOForm 4 sale8,750$44k40.9%UnusualSEC